Indian drugmakers are preparing for the launch of copycat weight-loss drugs as the world moves towards the patent expiry of ...

Slickly designed websites. Unbelievable markdowns. A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable ...

The UK’s drug’s watchdog has warned people over the use of counterfeit medications which could contain insulin - with many ...

In general, when a person prepares for a surgery, the guidance is to fast before going under anesthesia– but for patients, on gGLP-1's there may still be gastric juices, in the stomach, since the ...

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...

Moderation and self-control used to serve as WeightWatchers' main talking points, but the company has since transitioned to ...

The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...

No matter how much she ate, she never felt satisfied. But after starting a non-FDA approved GLP-1 agonist—an injectable drug similar to the diabetes drug Ozempic and the weight-loss drug Wegovy—last ...

According to a new study published in the journal Alzheimer's & Dementia, Semaglutide, the active ingredient in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease in people with Type 2 ...

Since Eli Lilly's Mounjaro and Novo Nordisk's Wegovy and Ozempic fell into shortage in late 2022, compounding pharmacies have been manufacturing their respective generics, tirzepatide and semaglutide.

Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...